IMMEDIATE Therapeutics

top of page

State of Possible: IMMEDIATE Therapeutics is developing a medicine for the critical time before heart attack sufferers make it to the hospital

CEO Atul Deshpande describes how every minute counts after a heart attack yet patients typically do not receive and medicine until they reach the hospital. He explains what IMMEDIATE's solution is, which is phase 3 ready and has a SPA from FDA.

Company News

2 days ago

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page

State of Possible: IMMEDIATE Therapeutics is developing a medicine for the critical time before heart attack sufferers make it to the hospital

Follow BiotechTV

Sponsors

Sponsor Spotlight